Xaira Funding & Investors
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.
xaira.comTotal Amount Raised: $1,000,000,000
Xaira Funding Rounds
Series A
$1,000,000,000
Series A Investors
Arch Venture PartnersForesite CapitalParker Institute for Cancer ImmunotherapySequoia CapitalMenlo VenturesNew Enterprise Associates (NEA)Lightspeed Venture PartnersByers CapitalR-Squared VenturesF-Prime CapitalTwo Sigma VenturesSV AngelLux Capital
Funding info provided by Diffbot.